the fetus of common patterns of prenatal alcohol exposure (PAE) e.g. low level or sporadic drinking. Guidelines recommend abstinence as the safest option, creating problems for those advising women who drink at these levels before pregnancy recognition or beyond. The Asking QUestions about Alcohol (AQUA) study aimed to accurately measure PAE and account for important cofactors, to reduce uncertainty about child outcomes.
King Edward Memorial Hospital Between 2013 and 2015, both the UK Regulatory Agency and TGA released medication notifications regarding the safety of codeine in children, including those exposed via breastfeeding. The initial findings indicated that caution be observed in mothers taking codeine-containing products whilst breastfeeding, and in late 2015 advised to avoid codeine-containing products. A pharmacist-led obstetric medicines information service (OMIS) implemented changes to their advice according to the above recommendations.
To evaluate information provided by pharmacists regarding safe use of codeine-containing products in breastfeeding following safety notifications in 2013 and 2015.
External calls to the OMIS between January 2001-June 2016 were analysed. Enquiries were sorted into codeine related enquiries in breastfeeding and the information categorised into 3 categories: considered safe; caution recommended; and no longer recommended.
The OMIS received 37,374 calls during this time. 2%(n = 753) of calls were codeine related. 449 of these (59%) related to codeine safety information in breastfeeding. Between 2001 and 2012, 336 calls were received with 67%(n = 225) categorised as considered safe to use, 31% (n = 103) were categorised as caution recommended and 2%(n = 8) were categorised as no longer recommended in breastfeeding. Following the notifications, between 2013 and 2015, 101 calls were received with 64%(n = 65) categorised as caution recommended, 34%(n = 34) categorised as considered safe to use, and 2%(n = 2) categorised as no longer recommended in breastfeeding. In 2016 alone, 12 codeine related calls were received and all recommended that codeine be avoided.
Conclusion Methods: Medical records of 50 patients that had been administered carboprost for PPH were assessed; risk factors identified and total blood loss used as a measurable endpoint. Blood loss results for 50 patients administered dinoprost were also obtained as a point of comparison.
Results: 4% of patients(n = 2) who received carboprost had documentation to indicate adherence to the PPH guideline. 70% (n = 35) of patients received either oxytocin and/or ergometrine prior to being administered carboprost, however documentation was inadequate to verify guideline adherence. The most common risk factor for PPH was delivery by caesarean section with 74% of patients(n = 37) having a caesarean section. Followed by Induction of labour at 46%(n = 23) and the presence of an existing medical condition at 28%(n = 14). Risk factors of Age >35 years and an over-distressed uterus was 24%(n = 12); Antepartum Haemorrhage, Asian ethnicity and a BMI > 35 were the fifth most common risk factor at 20%(n = 10) each. There was no significant difference(p = 0.13) in blood loss between patients administered carboprost (=1537 AE 858 mL) and those administered dinoprost (=1719 AE 778 mL). 26% (n = 13) of patients were also administered misoprostol, despite this not being included in the current guideline.
Conclusions: Further education on guideline adherence and appropriate documentation is required as inconsistent documentation made assessment of adherence difficult. Multiple risk factors were identified to contribute to PPH in this audit. Mercy Hospital for Women Background: Clinical photography has been contributing to the care of patients in medicine since its inception. Smart phone technology has made clinical photography more accessible to medical staff. This has caused increased medico-legal concerns, particularly regarding patient privacy and confidentiality.
